258 related articles for article (PubMed ID: 25325389)
1. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.
Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
Mol Pharm; 2014 Nov; 11(11):4228-37. PubMed ID: 25325389
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
Zhang S; Lee TWY; Chow AHL
Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
[TBL] [Abstract][Full Text] [Related]
3. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
[TBL] [Abstract][Full Text] [Related]
4. The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2015 May; 12(5):1477-84. PubMed ID: 25894099
[TBL] [Abstract][Full Text] [Related]
5. Correlation between molecular mobility and physical stability of amorphous itraconazole.
Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
Mol Pharm; 2013 Feb; 10(2):694-700. PubMed ID: 23198856
[TBL] [Abstract][Full Text] [Related]
6. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
7. Molecular mobility in glassy dispersions.
Mehta M; McKenna GB; Suryanarayanan R
J Chem Phys; 2016 May; 144(20):204506. PubMed ID: 27250315
[TBL] [Abstract][Full Text] [Related]
8. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
[TBL] [Abstract][Full Text] [Related]
9. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.
Miyazaki T; Aso Y; Yoshioka S; Kawanishi T
Int J Pharm; 2011 Apr; 407(1-2):111-8. PubMed ID: 21277962
[TBL] [Abstract][Full Text] [Related]
10. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
Mistry P; Mohapatra S; Gopinath T; Vogt FG; Suryanarayanan R
Mol Pharm; 2015 Sep; 12(9):3339-50. PubMed ID: 26070543
[TBL] [Abstract][Full Text] [Related]
11. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
Dalsania S; Sharma J; Munjal B; Bansal AK
Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
[TBL] [Abstract][Full Text] [Related]
12. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
Rumondor AC; Stanford LA; Taylor LS
Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
[TBL] [Abstract][Full Text] [Related]
14. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
16. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
18. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
19. Effect of Water on Molecular Mobility and Physical Stability of Amorphous Pharmaceuticals.
Mehta M; Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2016 Apr; 13(4):1339-46. PubMed ID: 26954586
[TBL] [Abstract][Full Text] [Related]
20. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
